Skip to main content
Top
Published in: Allergy, Asthma & Clinical Immunology 1/2010

Open Access 01-12-2010 | Research

Eotaxin and FGF enhance signaling through an Extracellular signal-related kinase (ERK)-dependent pathway in the pathogenesis of Eosinophilic Esophagitis

Authors: Jennifer J Huang, Jae Won Joh, Judy Fuentebella, Anup Patel, Tammie Nguyen, Scott Seki, Lisa Hoyte, Neha Reshamwala, Christine Nguyen, Anthony Quiros, Dorsey Bass, Eric Sibley, William Berquist, Kenneth Cox, John Kerner, Kari C Nadeau

Published in: Allergy, Asthma & Clinical Immunology | Issue 1/2010

Login to get access

Abstract

Background

Eosinophilic esophagitis (EoE) is characterized by the inflammation of the esophagus and the infiltration of eosinophils into the esophagus, leading to symptoms such as dysphagia and stricture formation. Systemic immune indicators like eotaxin and fibroblast growth factor were evaluated for possible synergistic pathological effects. Moreover, blood cells, local tissue, and plasma from EoE and control subjects were studied to determine if the localized disease was associated with a systemic effect that correlated with presence of EoE disease.

Method

Real-time polymerase chain reaction from peripheral blood mononuclear cells (PBMC), immunohistochemistry from local esophageal biopsies, fluid assays on plasma, and fluorescence-activated cell sorting on peripheral blood cells from subjects were used to study the systemic immune indicators in newly diagnosed EoE (n = 35), treated EoE (n = 9), Gastroesophageal reflux disease (GERD) (n = 8), ulcerative colitis (n = 5), Crohn's disease (n = 5), and healthy controls (n = 8).

Result

Of the transcripts tested for possible immune indicators, we found extracellular signal-regulated kinase (ERK), Bcl-2, bFGF (basic fibroblast growth factor), and eotaxin levels were highly upregulated in PBMC and associated with disease presence of EoE. Increased FGF detected by immunohistochemistry in esophageal tissues and in PBMC was correlated with low levels of pro-apoptotic factors (Fas, Caspase 8) in PBMC from EoE subjects. Plasma-derived bFGF was shown to be the most elevated and most specific in EoE subjects in comparison to healthy controls and disease control subjects.

Conclusion

We describe for the first time a possible mechanism by which increased FGF is associated with inhibiting apoptosis in local esophageal tissues of EoE subjects as compared to controls. Eotaxin and FGF signaling pathways share activation through the ERK pathway; together, they could act to increase eosinophil activation and prolong the half-life of eosinophils in local tissues of the esophagus in EoE subjects.
Appendix
Available only for authorised users
Literature
1.
go back to reference Norvell JM, Venarske D, Hummell DS: Eosinophilic esophagitis: an allergist's approach. Ann Allergy Asthma Immunol. 2007, 98 (3): 207-14. 10.1016/S1081-1206(10)60708-9.CrossRefPubMed Norvell JM, Venarske D, Hummell DS: Eosinophilic esophagitis: an allergist's approach. Ann Allergy Asthma Immunol. 2007, 98 (3): 207-14. 10.1016/S1081-1206(10)60708-9.CrossRefPubMed
2.
go back to reference Aceves SS, Newbury RO, Dohil R, Schwimmer J, Bastian JF: Distinguishing eosinophilic esophagitis in pediatric patients: clinical, endoscopic, and histologic features of an emerging disorder. J Clin Gastroenterol. 2007, 41 (3): 252-6. 10.1097/01.mcg.0000212639.52359.f1.CrossRefPubMed Aceves SS, Newbury RO, Dohil R, Schwimmer J, Bastian JF: Distinguishing eosinophilic esophagitis in pediatric patients: clinical, endoscopic, and histologic features of an emerging disorder. J Clin Gastroenterol. 2007, 41 (3): 252-6. 10.1097/01.mcg.0000212639.52359.f1.CrossRefPubMed
3.
go back to reference Katzka DA: Eosinophilic esophagitis: it's all in the family. Gastrointest Endosc. 2007, 65 (2): 335-6. 10.1016/j.gie.2006.10.049.CrossRefPubMed Katzka DA: Eosinophilic esophagitis: it's all in the family. Gastrointest Endosc. 2007, 65 (2): 335-6. 10.1016/j.gie.2006.10.049.CrossRefPubMed
4.
go back to reference Ferguson DD, Foxx-Orenstein AE: Eosinophilic esophagitis: an update. Dis Esophagus. 2007, 20 (1): 2-8. 10.1111/j.1442-2050.2007.00649.x.CrossRefPubMed Ferguson DD, Foxx-Orenstein AE: Eosinophilic esophagitis: an update. Dis Esophagus. 2007, 20 (1): 2-8. 10.1111/j.1442-2050.2007.00649.x.CrossRefPubMed
5.
go back to reference Noel RJ, Putnam PE, Rothenberg ME: Eosinophilic esophagitis. N Engl J Med. 2004, 351 (9): 940-1. 10.1056/NEJM200408263510924.CrossRefPubMed Noel RJ, Putnam PE, Rothenberg ME: Eosinophilic esophagitis. N Engl J Med. 2004, 351 (9): 940-1. 10.1056/NEJM200408263510924.CrossRefPubMed
6.
go back to reference Buckmeier B, Rothenberg M, Collins M: The incidence and prevalence of eosinophilic esophagitis. J Allergy Clin Immunol. 2008, 121 (2): S71-10.1016/j.jaci.2007.12.281.CrossRef Buckmeier B, Rothenberg M, Collins M: The incidence and prevalence of eosinophilic esophagitis. J Allergy Clin Immunol. 2008, 121 (2): S71-10.1016/j.jaci.2007.12.281.CrossRef
7.
go back to reference Furuta GT, Straumann A: Review article: the pathogenesis and management of eosinophilic oesophagitis. Aliment Pharmacol Ther. 2006, 24 (2): 173-82. 10.1111/j.1365-2036.2006.02984.x.CrossRefPubMed Furuta GT, Straumann A: Review article: the pathogenesis and management of eosinophilic oesophagitis. Aliment Pharmacol Ther. 2006, 24 (2): 173-82. 10.1111/j.1365-2036.2006.02984.x.CrossRefPubMed
8.
go back to reference Liacouras CA, Spergel JM, Ruchelli E, Verma R, Mascarenhas M, Semeao E, Flick J, Kelly J, Brown-Whitehorn T, Mamula JE, Markowitz : Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005, 3 (12): 1198-206. 10.1016/S1542-3565(05)00885-2.CrossRefPubMed Liacouras CA, Spergel JM, Ruchelli E, Verma R, Mascarenhas M, Semeao E, Flick J, Kelly J, Brown-Whitehorn T, Mamula JE, Markowitz : Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005, 3 (12): 1198-206. 10.1016/S1542-3565(05)00885-2.CrossRefPubMed
9.
go back to reference Kelly KJ, Lazenby AJ, Rowe PC, Yardley JH, Perman JA, Sampson HA: Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology. 1995, 109 (5): 1503-12. 10.1016/0016-5085(95)90637-1.CrossRefPubMed Kelly KJ, Lazenby AJ, Rowe PC, Yardley JH, Perman JA, Sampson HA: Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology. 1995, 109 (5): 1503-12. 10.1016/0016-5085(95)90637-1.CrossRefPubMed
10.
go back to reference Fogg MI, Ruchelli E, Spergel JM: Pollen and eosinophilic esophagitis. J Allergy Clin Immunol. 2003, 112 (4): 796-7. 10.1016/S0091-6749(03)01715-9.CrossRefPubMed Fogg MI, Ruchelli E, Spergel JM: Pollen and eosinophilic esophagitis. J Allergy Clin Immunol. 2003, 112 (4): 796-7. 10.1016/S0091-6749(03)01715-9.CrossRefPubMed
11.
go back to reference Mishra A, Hogan S, Brandt EB, Rothenberg ME: An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest. 2001, 107 (1): 83-90. 10.1172/JCI10224.PubMedCentralCrossRefPubMed Mishra A, Hogan S, Brandt EB, Rothenberg ME: An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest. 2001, 107 (1): 83-90. 10.1172/JCI10224.PubMedCentralCrossRefPubMed
12.
go back to reference Spergel JM, Beausoleil JL, Mascarenhas M, Liacouras CA: The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol. 2002, 109 (2): 363-8. 10.1067/mai.2002.121458.CrossRefPubMed Spergel JM, Beausoleil JL, Mascarenhas M, Liacouras CA: The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol. 2002, 109 (2): 363-8. 10.1067/mai.2002.121458.CrossRefPubMed
13.
go back to reference Chehade M, Sampson HA: Epidemiology and etiology of eosinophilic esophagitis. Gastrointest Endosc Clin N Am. 2008, 18 (1): 33-44. 10.1016/j.giec.2007.09.002. viiiCrossRefPubMed Chehade M, Sampson HA: Epidemiology and etiology of eosinophilic esophagitis. Gastrointest Endosc Clin N Am. 2008, 18 (1): 33-44. 10.1016/j.giec.2007.09.002. viiiCrossRefPubMed
14.
go back to reference Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C, Putnam PE, Bonis P, Hassall E, Straumann A, Rothenberg ME: Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007, 133 (4): 1342-63. 10.1053/j.gastro.2007.08.017.CrossRefPubMed Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C, Putnam PE, Bonis P, Hassall E, Straumann A, Rothenberg ME: Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007, 133 (4): 1342-63. 10.1053/j.gastro.2007.08.017.CrossRefPubMed
15.
go back to reference Straumann A: Eosinophilic esophagitis: a rapidly emerging disease. Esophagus. 2008, 5 (4): 177-183. 10.1007/s10388-008-0172-x.CrossRef Straumann A: Eosinophilic esophagitis: a rapidly emerging disease. Esophagus. 2008, 5 (4): 177-183. 10.1007/s10388-008-0172-x.CrossRef
17.
go back to reference Karsan A, Yee E, Poirier GG, Zhou R, Craig JM, Harlan : Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2-dependent and independent mechanisms. Am J Pathol. 1997, 151 (6): 1775-84.PubMedCentralPubMed Karsan A, Yee E, Poirier GG, Zhou R, Craig JM, Harlan : Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2-dependent and independent mechanisms. Am J Pathol. 1997, 151 (6): 1775-84.PubMedCentralPubMed
18.
go back to reference Pintucci G, Moscatelli D, Saponara F, Biernacki PR, Baumann FG, Bizekis C, Galloway AC, Basilico C, Mignatti : Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells. FASEB J. 2002, 16 (6): 598-600.PubMed Pintucci G, Moscatelli D, Saponara F, Biernacki PR, Baumann FG, Bizekis C, Galloway AC, Basilico C, Mignatti : Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells. FASEB J. 2002, 16 (6): 598-600.PubMed
19.
go back to reference Kampen GT, Stafford S, Adachi T, Jinquan T, Quan S, Grant JA, Skov PS, Poulsen LK, Alam R: Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood. 2000, 95 (6): 1911-7.PubMed Kampen GT, Stafford S, Adachi T, Jinquan T, Quan S, Grant JA, Skov PS, Poulsen LK, Alam R: Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood. 2000, 95 (6): 1911-7.PubMed
21.
go back to reference Mishra A, Rothenberg ME: Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology. 2003, 125 (5): 1419-27. 10.1016/j.gastro.2003.07.007.CrossRefPubMed Mishra A, Rothenberg ME: Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology. 2003, 125 (5): 1419-27. 10.1016/j.gastro.2003.07.007.CrossRefPubMed
22.
go back to reference Blanchard C, Mishra A, Saito-Akei H, Monk P, Anderson I, Rothenberg ME: Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354). Clin Exp Allergy. 2005, 35 (8): 1096-103. 10.1111/j.1365-2222.2005.02299.x.CrossRefPubMed Blanchard C, Mishra A, Saito-Akei H, Monk P, Anderson I, Rothenberg ME: Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354). Clin Exp Allergy. 2005, 35 (8): 1096-103. 10.1111/j.1365-2222.2005.02299.x.CrossRefPubMed
23.
go back to reference Stenfeldt AL, Wenneras C: Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils. Immunology. 2004, 112 (4): 605-14. 10.1111/j.1365-2567.2004.01906.x.PubMedCentralCrossRefPubMed Stenfeldt AL, Wenneras C: Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils. Immunology. 2004, 112 (4): 605-14. 10.1111/j.1365-2567.2004.01906.x.PubMedCentralCrossRefPubMed
24.
go back to reference Mulder DJ, Pacheco I, Hurlbut DJ, Mak N, Furuta GT, MacLeod RJ, Justinich CJ: FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis. Gut. 2009, 58 (2): 166-73. 10.1136/gut.2008.157628.PubMedCentralCrossRefPubMed Mulder DJ, Pacheco I, Hurlbut DJ, Mak N, Furuta GT, MacLeod RJ, Justinich CJ: FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis. Gut. 2009, 58 (2): 166-73. 10.1136/gut.2008.157628.PubMedCentralCrossRefPubMed
25.
go back to reference Dinbergs ID, Brown L, Edelman ER: Cellular response to transforming growth factor-beta1 and basic fibroblast growth factor depends on release kinetics and extracellular matrix interactions. J Biol Chem. 1996, 271 (47): 29822-9. 10.1074/jbc.271.47.29822.CrossRefPubMed Dinbergs ID, Brown L, Edelman ER: Cellular response to transforming growth factor-beta1 and basic fibroblast growth factor depends on release kinetics and extracellular matrix interactions. J Biol Chem. 1996, 271 (47): 29822-9. 10.1074/jbc.271.47.29822.CrossRefPubMed
26.
go back to reference Lawrence A, Khanna D, Misra R, Aggarwal A: Increased expression of basic fibroblast growth factor in skin of patients with systemic sclerosis. Dermatol Online J. 2006, 12 (1): 2-PubMed Lawrence A, Khanna D, Misra R, Aggarwal A: Increased expression of basic fibroblast growth factor in skin of patients with systemic sclerosis. Dermatol Online J. 2006, 12 (1): 2-PubMed
27.
go back to reference Chehade M, Sampson HA, Morotti RA, Magid MS: Esophageal subepithelial fibrosis in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2007, 45 (3): 319-28. 10.1097/MPG.0b013e31806ab384.CrossRefPubMed Chehade M, Sampson HA, Morotti RA, Magid MS: Esophageal subepithelial fibrosis in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2007, 45 (3): 319-28. 10.1097/MPG.0b013e31806ab384.CrossRefPubMed
28.
go back to reference Hoshino M, Takahashi M, Aoike N: Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol. 2001, 107 (2): 295-301. 10.1067/mai.2001.111928.CrossRefPubMed Hoshino M, Takahashi M, Aoike N: Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol. 2001, 107 (2): 295-301. 10.1067/mai.2001.111928.CrossRefPubMed
29.
go back to reference Antoine M: Expression and function of fibroblast growth factor (FGF) 9 in hepatic stellate cells and its role in toxic liver injury. Biochem Biophys Res Commun. 2007, 361 (2): 335-41. 10.1016/j.bbrc.2007.06.189.CrossRefPubMed Antoine M: Expression and function of fibroblast growth factor (FGF) 9 in hepatic stellate cells and its role in toxic liver injury. Biochem Biophys Res Commun. 2007, 361 (2): 335-41. 10.1016/j.bbrc.2007.06.189.CrossRefPubMed
Metadata
Title
Eotaxin and FGF enhance signaling through an Extracellular signal-related kinase (ERK)-dependent pathway in the pathogenesis of Eosinophilic Esophagitis
Authors
Jennifer J Huang
Jae Won Joh
Judy Fuentebella
Anup Patel
Tammie Nguyen
Scott Seki
Lisa Hoyte
Neha Reshamwala
Christine Nguyen
Anthony Quiros
Dorsey Bass
Eric Sibley
William Berquist
Kenneth Cox
John Kerner
Kari C Nadeau
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Allergy, Asthma & Clinical Immunology / Issue 1/2010
Electronic ISSN: 1710-1492
DOI
https://doi.org/10.1186/1710-1492-6-25

Other articles of this Issue 1/2010

Allergy, Asthma & Clinical Immunology 1/2010 Go to the issue